Norpsilocin

Norpsilocin
Clinical data
Other names	4-HO-NMT; 4-OH-NMT; 4-HO-MMT; 4-OH-MMT; 4-Hydroxy-NMT; 4-Hydroxy-MMT; 4-Hydroxy-N-methyltryptamine; 4-Hydroxy-mono-methyltryptamine; N-Desmethylpsilocin; Desmethylpsilocin; AS-63499; PLZ-1017; PLZ1017
Drug class	Serotonin receptor modulator; Non-hallucinogenic Serotonin 5-HT2A receptor agonist
ATC code	None;
Identifiers
	IUPAC name 3-[2-(methylamino)ethyl]-1H-indol-4-ol;
CAS Number	28363-70-4;
PubChem CID	14107683;
ChemSpider	27283888;
UNII	TL6QDJ5TMQ;
ChEMBL	ChEMBL4648350;
CompTox Dashboard (EPA)	DTXSID901336988 ;
Chemical and physical data
Formula	C11H14N2O
Molar mass	190.246 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CNCCC1=CNC2=C1C(=CC=C2)O;
	InChI InChI=1S/C11H14N2O/c1-12-6-5-8-7-13-9-3-2-4-10(14)11(8)9/h2-4,7,12-14H,5-6H2,1H3; Key:MTJOWJUQGYWRHT-UHFFFAOYSA-N;

Norpsilocin, also known as 4-hydroxy-N-methyltryptamine (4-HO-NMT), is a tryptamine alkaloid recently discovered in 2017 in the psychedelic mushroom Psilocybe cubensis. It is hypothesized to be a dephosphorylated metabolite of baeocystin.